Amanote Research
Register
Sign In
Targeting Heat Shock Protein 90 and Its Downstream Signaling Hubs for the Treatment of Mantle Cell Lymphoma
Hematological Oncology
- United Kingdom
doi 10.1002/hon.2439_171
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2017
Authors
H. Liu
P. Zhang
D. Shang
X. Shi
Z. Lu
L. Liu
M. Shen
Z. Tu
Publisher
Wiley
Related search
B-Cell CLL/lymphoma 6 (BCL6); Heat Shock Protein 90 (Hsp90)
Science-Business eXchange
Crowding Activates Heat Shock Protein 90
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Advances in the Discovery and Development of Heat-Shock Protein 90 Inhibitors for Cancer Treatment
Expert Opinion on Drug Discovery
Drug Discovery
Heat Shock Protein 90 (HSP90AA1; Hsp90)
Science-Business eXchange
Regulation of Embryonic Stem Cell Pluripotency by Heat Shock Protein 90
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
Emerging Therapy for the Treatment of Mantle Cell Lymphoma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Targeting Heat Shock Protein 90 With CUDC-305 Overcomes Erlotinib Resistance in Non-Small Cell Lung Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Heat Shock Protein 90 Inhibitors in the Treatment of Cancer: Current Status and Future Directions
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
Stressing Rac, Ras, and Downstream Heat Shock Protein 70
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology